Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

The total number of fall-risk-increasing drugs and PIMs at discharge was significantly lower in the intervention group than in the usual care group (1.4 ± 1.2 for the intervention group vs 2.1 ± 1.4 for the usual care group; p = 0.01; and 0.8 ± 0.8 for the intervention group vs 1.1 ± 1.0 for the usual care group; p = 0.03, respectively).Characteristics of 164 elderly patients with hip fractureCharacteristicsIntervention N = 32Usual care N = 132 P-valuePatient characteristics Age, mean ± SD83.8 ± 6.285.1 ± 6.70.28 Men, n (%)7 (21.9)28 (21.2)1.00 Institutional resident, n (%)7 (21.9)47 (35.6)0.15CCI, mean ± SD2.7 ± 1.62.0 ± 1.80.04Number of medications at admission Total, mean ± SD9.2 ± 2.57.8 ± 2.50.01 5 to 8 medications, n (%)15 (46.9)88 (66.7)0.04 9 to 12 medications, n (%)13 (40.6)38 (28.8)0.21 13 or more medications, n (%)4 (12.5)6 (4.5)0.11Number of medications at discharge Total, mean ± SD4.5 ± 2.66.8 ± 2.4< 0.001 0 to 4 medications, n (%)18 (56.3)21 (15.9)< 0.001 5 to 8 medications, n (%)13 (40.6)85 (64.4)0.02 9 to 12 medications, n (%)0 (0.0)23 (17.4)0.02 13 or more medications, n (%)1 (3.1)3 (2.3)1.00Fall-risk-increasing drugsa at admission Total number, mean ± SD2.9 ± 1.32.6 ± 1.40.22 0 to 2 medications, n (%)13 (40.6)62 (47.0)0.56 3 to 5 medications, n (%)16 (50.0)65 (49.2)1.00 6 or more medications, n (%)1 (3.1)5 (3.8)1.00Fall-risk-increasing drugsa at discharge Total number, mean ± SD1.4 ± 1.22.1 ± 1.40.01 0 to 2 medications, n (%)27 (84.4)80 (60.6)0.01 3 to 5 medications, n (%)5 (15.6)50 (37.9)0.02 6 or more medications, n (%)0 (0.0)2 (1.5)1.00PIMsb at admission Total number, mean ± SD1.5 ± 0.81.3 ± 1.10.19 0 to 1 medication, n (%)17 (53.1)83 (62.9)0.32 2 to 3 medications, n (%)15 (46.9)44 (33.3)0.22 4 or more medications, n (%)0 (0.0)5 (3.8)0.58PIMsb at discharge Total number, mean ± SD0.8 ± 0.81.1 ± 1.00.03 0 to 1 medication, n (%)27 (84.4)89 (67.4)0.08 2 to 3 medications, n (%)5 (15.6)41 (31.1)0.12 4 or more medications, n (%)0 (0.0)2 (1.5)1.00Past medical history, n (%) Dementia14 (43.8)55 (41.7)0.84 Heart diseasec 5 (15.6)28 (21.2)0.63 Stroke11 (34.4)28 (21.2)0.16 Diabetes mellitus6 (18.6)35 (26.5)0.50 Hip fracture2 (6.3)19 (14.4)0.37 Any fracture14 (43.8)44 (33.3)0.31 Current smoker, n (%)1 (3.1)11 (8.3)0.46 Current drinker, n (%)3 (9.4)10 (7.6)0.72Type of hip fracture, n (%) Intracapsular fracture17 (53.1)60 (45.5)0.55 Intertrochanteric fracture11 (36.7)67 (50.8)0.12 Subtrochanteric fracture4 (12.5)4 (3.0)0.05 Others0 (0.0)1 (0.8)1.00Management during admission Surgery, n (%)31 (96.9)129 (97.7)0.58 VTE prophylaxis, n (%)32 (100)130 (98.5)1.00 Perioperative antibiotics, n (%)31 (100)129 (100)1.00 Medical consultationd, n (%)7 (21.9)41 (31.7)0.39Osteoporosis treatment, n (%) PTH analogue2 (6.3)2 (1.5)0.17 Bisphosphonate3 (9.4)6 (4.5)0.38 Vitamin D3 (9.4)21 (15.9)0.42 aFall-risk-increasing drugs included antihypertensives, alpha-adrenoreceptor antagonists, opioids, dopaminergic agents, antipsychotics, anxiolytics, hypnotics and antidepressants bPIMs were defined based on the 2015 American Geriatric Society Beers Criteria cHeart disease included angina, myocardial infarction and heart failure dThis category included consultation about medical problems other than polypharmacy

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Observational study.

Observational study

Observes exposures and outcomes without assigning the exposure; the subtype is not established here.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Intervention to improve the appropriate use of polypharmacy for older patients with hip fractures: an observational study

Source: Article title.

All hip fracture patients aged 65 years or older and prescribed 5 or more medications at admission from January 2015 to December 2016 were included in the study.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Intervention to improve the appropriate use of polypharmacy for older patients with hip fractures: an observational study

Observational study · BMC Geriatrics · 2017

Original publication title

Intervention to improve the appropriate use of polypharmacy for older patients with hip fractures: an observational study

Junpei Komagamine; Kazuhiko Hagane

© The Author(s). 2017

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

The intervention to improve appropriate polypharmacy was associated with a reduction in potentially inappropriate medications but not an improvement in clinical outcomes. This intervention, which focused only on polypharmacy, may not effectively improve outcomes for elderly patients with hip fractures.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Polypharmacy is frequently observed in hip fracture patients. Although it is associated with an increased risk of hip fracture, polypharmacy often continues after hip fracture recovery. This study aimed to evaluate the effectiveness of an intervention to improve appropriate polypharmacy for elderly patients admitted to the hospital for hip fractures.

Source: Background

Abstract: What methods does the paper describe?

We conducted a retrospective observational study to compare the outcomes of patients receiving the intervention (n = 32) with those of patients who received usual care (n = 132). All hip fracture patients aged 65 years or older and prescribed 5 or more medications at admission from January 2015 to December 2016 were included in the study. The intervention consisted of an assessment by internal medicine physicians of the appropriateness of polypharmacy and the de-prescription of any unnecessary medications during the patients’ hospital stay.

The primary composite outcome was death or the first occurrence of any new fracture. Comparisons between the intervention and usual care groups were analyzed using binary logistic regression.

Source: Methods

Abstract: Electronic supplementary material

The online version of this article (10.1186/s12877-017-0681-3) contains supplementary material, which is available to authorized users.

Source: Electronic supplementary material

Abstract: Results

A total of 164 patients were included in the study. The mean patient age was 84.8 years, and the mean numbers of prescribed medications and potentially inappropriate medications at admission were 8.0 and 1.3, respectively. The mean follow-up period was 8.0 months. The primary composite outcome occurred in 35 (21.3%) patients. The total number of potentially inappropriate medications at discharge was significantly lower in the intervention group than in the usual care group (0.8 ± 0.8 for the intervention group vs 1.1 ± 1.0 for the usual care group; p = 0.03).

However, no significant differences in the primary composite outcome were found between the intervention and usual care groups (7 in the intervention group and 28 in the usual care group, odds ratio 1.04, 95% CI 0.41 to 2.65; p = 1.00).

Source: Results

Abstract: Conclusions

The intervention to improve appropriate polypharmacy was associated with a reduction in potentially inappropriate medications but not an improvement in clinical outcomes. This intervention, which focused only on polypharmacy, may not effectively improve outcomes for elderly patients with hip fractures.

Source: Conclusions
Authors’ abstract

Background

Polypharmacy is frequently observed in hip fracture patients. Although it is associated with an increased risk of hip fracture, polypharmacy often continues after hip fracture recovery. This study aimed to evaluate the effectiveness of an intervention to improve appropriate polypharmacy for elderly patients admitted to the hospital for hip fractures.

Methods

We conducted a retrospective observational study to compare the outcomes of patients receiving the intervention (n = 32) with those of patients who received usual care (n = 132). All hip fracture patients aged 65 years or older and prescribed 5 or more medications at admission from January 2015 to December 2016 were included in the study. The intervention consisted of an assessment by internal medicine physicians of the appropriateness of polypharmacy and the de-prescription of any unnecessary medications during the patients’ hospital stay.

The primary composite outcome was death or the first occurrence of any new fracture. Comparisons between the intervention and usual care groups were analyzed using binary logistic regression.

Results

A total of 164 patients were included in the study. The mean patient age was 84.8 years, and the mean numbers of prescribed medications and potentially inappropriate medications at admission were 8.0 and 1.3, respectively. The mean follow-up period was 8.0 months. The primary composite outcome occurred in 35 (21.3%) patients. The total number of potentially inappropriate medications at discharge was significantly lower in the intervention group than in the usual care group (0.8 ± 0.8 for the intervention group vs 1.1 ± 1.0 for the usual care group; p = 0.03).

However, no significant differences in the primary composite outcome were found between the intervention and usual care groups (7 in the intervention group and 28 in the usual care group, odds ratio 1.04, 95% CI 0.41 to 2.65; p = 1.00).

Conclusions

The intervention to improve appropriate polypharmacy was associated with a reduction in potentially inappropriate medications but not an improvement in clinical outcomes. This intervention, which focused only on polypharmacy, may not effectively improve outcomes for elderly patients with hip fractures.

Trial registration

UMIN-CTR UMIN000025495. Retrospectively registered 2 January 2017.

Electronic supplementary material

The online version of this article (10.1186/s12877-017-0681-3) contains supplementary material, which is available to authorized users.

Publication and source details

Original title: Intervention to improve the appropriate use of polypharmacy for older patients with hip fractures: an observational study

Junpei Komagamine; Kazuhiko Hagane

BMC Geriatrics · 2017

© The Author(s). 2017https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T19:21:46.502545+00:00

DOI: 10.1186/s12877-017-0681-3 · PMC5732518